TABLE 2.

The application of inorganic nanoparticle-based drug delivery system.

Drug	Carrier	Disease	Structure	References
Monocyte	As@GNC	Osteomyelitis	Nanoparticle	Shi et al., 2020a
Celecoxib	QD	Local edema	Nanoparticle	Kalangi et al., 2018
SAM	N-GQD	NA	Nanoparticle	Sameer Kumar et al., 2018
Diclofenac sodium	CNT	Arthritic pain	Nanoparticle	Spizzirri et al., 2013
Ketoprofen	PEO/PETA-MWCNT	NA	Nanotube	Im et al., 2010

As@GNC, aspirin-containing gold nanocage; CNT, Carbon nanotube; NA, not applicable; PEO/PETA-MWCNT, poly-ethylene oxide/Pentaerythritol triacrylate-multi-walled carbon nanotubes; QD, Quantum dot; SAM, sodium 10-amino-2-methoxyundecanoate.